Research into multiple sclerosis (MS) is ongoing, focusing on when the condition develops and how to diagnose it quickly. A recent study indicated that individuals who later developed MS frequently utilized medical services as much as 15 years before their symptoms manifested.
- Findings suggest that the onset of multiple sclerosis may occur earlier than previously believed, paving the way for better management options.
This research, detailed in JAMA Network Open, examined healthcare usage over a 25-year period leading up to the onset of MS symptoms.
When comparing individuals with MS to those without, the former group showed significantly higher healthcare service usage in the 15 years preceding their condition’s onset.
Researchers identified particular reasons for these visits, with mental health issues and vague symptoms emerging as some of the earliest concerns.
The study indicates that the condition may begin earlier, which could enhance diagnosis and early treatment opportunities.
To gain insight into the early stages of MS, researchers focused on the prodromal phase, searching for data that predates earlier studies.
This particular study took place in British Columbia, Canada, and utilized insurance data, including hospital and doctor visit records. The British Columbia MS clinical database helped pinpoint when participants first experienced MS symptoms, alongside prescription data.
Researchers evaluated data from 2,038 individuals diagnosed with MS and compared this to a cohort of 10,182 without the condition.
After tracking doctor visits over 25 years leading up to symptom onset, researchers concentrated on the last 15 years for significant changes in healthcare interactions.
In that timeframe, participants diagnosed with MS had a notable uptick in visits for vague and undefined symptoms.
During the 14 years before symptoms appeared, there was a significant rise in visits related to mental health concerns—up 76% overall—along with injury-related appointments.
Twelve years prior to the onset, psychiatric consultations began to increase, marking a 159% rise by the last few years before symptoms emerged.
There was also a concerning rise in eye-related visits starting nine years before MS occurred, peaking in the year just prior to the onset.
In the last eight years before MS onset, the frequency of healthcare visits remained elevated, especially just before symptoms first appeared.
Visits regarding musculoskeletal conditions noticeably increased in the last five years before MS onset.
Moreover, boosts in emergency room visits occurred five years prior, with additional rises in radiology requests three years before and in neurology a year beforehand.
Most of the spikes in healthcare visits reached their peak during the year preceding MS symptoms, highlighting the urgency for better awareness around these early signs.
Other visit patterns shifted with time; for instance, endocrine-related consultations rose nine years ahead, while pregnancy-related visits declined during the two and five years before onset.
The data also pointed to surges in conditions like anxiety, depression, and dizziness in the years before symptoms appeared, notably increasing concerns like migraines and eye problems in the final year.
This evidence supports the theory that MS may begin well before diagnosis and highlights the need for continued research. Experts suggest early psychiatric symptoms could be significant indicators of MS, emerging years before any neurological issues surface.
While extensive follow-up was possible in this research, some limitations remain. For one, researchers lacked access to certain clinical details and only had data about the reasons for healthcare visits.
There’s also the potential for classification errors based on the data used. Additionally, determining the exact onset of MS symptoms is a complex tasks that can be influenced by memory bias and challenges in collecting medical histories.
Some participants might have had cases of MS that could have been diagnosed sooner. Conversely, individuals in the matched cohort might have had undiagnosed MS, despite not presenting symptoms.
The study focused specifically on individuals from British Columbia, mostly women, which somewhat limits the generalizability of the findings.
Plus, without collecting data on race or ethnicity, expanding that scope could yield more accurate insights. The analysis corrected for only a few factors statistically, which might have affected outcomes.
Dr. Burcu Zeydan from the Mayo Clinic, who wasn’t part of the study, issued some cautions. She pointed out:
“Many healthcare visits in the pre-MS diagnosis phase are often for vague, common issues such as headaches and fatigue. Since most of these individuals may never develop MS, there’s a risk of overdiagnosis and causing undue stress to families. Yet there’s also potential for missed opportunities in recognizing MS early.”
The research invites broader conversations regarding MS’s earliest stages and the underlying causes. According to study author Dr. Helen Tremlett from the University of British Columbia:
“MS may start earlier than we recognized before, which is crucial when thinking about its causes. Our findings suggest we need to evaluate much earlier than we currently do.”
Zeydan noted that identifying potential early warning signs could lead to individualized risk models in the future, possibly incorporating biomarkers for more accurate health assessments.
Ultimately, the goal would be to recognize those at high risk during the prodromal phase and offer proactive approaches to their MS care.
